Canada Buys 72 Million Coronavirus Vaccine Doses

The Government of Canada agreed to purchase up to 72 million doses of an adjuvanted COVID-19 vaccine beginning in 2021 from Sanofi and GSK on September 22, 2020. Both companies have vaccine manufacturing sites in Canada that are contributing to overall global COVID-19 vaccine development.

These companies initiated a Phase 1/2 study on September 3, 2020, with a total of 440 subjects and anticipate results in early December 2020, to support the initiation of a pivotal Phase 3 study before the end of 2020. If these data are sufficient for licensure application, it is planned to request regulatory approval in the first half of 2021.

In the aggregate, Canada has committed about $1 billion to buy at least 154 million doses of vaccines from (5) different companies.